- Global Pharma News & Resources

Endace Celebrates 20th Anniversary with Donation to The Glaucoma Foundation

Corporate gift provides dollar-for-dollar matching to donations received in the 2021 TGF Art Challenge to Celebrate Vision

London, UK – August 19, 2021 – As part of its twentieth anniversary celebration and its “year of giving back,” Endace is supporting The Glaucoma Foundation’s Art Challenge to Celebrate Vision with a corporate donation of US$20,000.

Glaucoma is the world’s leading cause of irreversible blindness and affects an estimated 80 million people, with a projected increase to 112 million by 2040. The Glaucoma Foundation is leading the fight against the disease by promoting early diagnosis and funding vital research to identify and develop novel approaches to preserve visual function and reverse blindness caused by glaucoma.

“It was important to us to mark this company milestone by making a difference. More than one million people per year are diagnosed with glaucoma. The Glaucoma Foundation’s mission to preserve and restore vision aligns strongly with our mission to provide visibility in networks,” said Stuart Wilson, CEO of Endace.

“At Endace, we love to overcome difficult challenges, so helping The Glaucoma Foundation address the significant challenges of this debilitating condition feels like a very worthwhile project to support,” Wilson said.

“Endace’s generous donation to the second annual TGF Art Challenge will provide patients with help for today and hope for the future,” said Elena Sturman, President and CEO of The Glaucoma Foundation. “The Art Challenge acknowledges the wonders of vision and is key to our mission of identifying and funding innovative sight-saving research. We are thrilled to have Endace’s confidence and their wonderful boost to our initiative to engage artists and art lovers in the preservation of vision.”

Editor Details

Last Updated: 20-Aug-2021